Drug Shortage Report for (20MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP
| Report ID | 75200 |
| Drug Identification Number | 00437999 |
| Brand name | (20MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP |
| Common or Proper name | Potassium Chloride in 5% Dextrose Injection |
| Company Name | BAXTER CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | DEXTROSE POTASSIUM CHLORIDE SODIUM CHLORIDE |
| Strength(s) | 5G 150MG 450MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 1000 mL |
| ATC code | B05BB |
| ATC description | I.V. SOLUTIONS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2019-02-08 |
| Actual start date | 2019-02-08 |
| Estimated end date | 2019-02-12 |
| Actual end date | 2019-02-12 |
| Shortage status | Resolved |
| Updated date | 2019-02-13 |
| Company comments | JB1134 - 20 mmol Potassium Chloride in 5% Dextrose Injection USP or JB1424 - 20 mmol Potassium Chloride in 3.3% Dextrose and 0.3% Sodium Chloride Injection USP are available as possible alternatives. For questions or concerns contact Baxter customer care (1.888.719.9955) or your local representative. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2019-02-13 | French | Compare |
| v4 | 2019-02-13 | English | Compare |
| v3 | 2019-02-09 | English | Compare |
| v2 | 2019-02-08 | French | Compare |
| v1 | 2019-02-08 | English | Compare |
Showing 1 to 5 of 5